Transplantation Direct (Sep 2023)

Delayed Graft Function Among Kidney Transplant Recipients Is Associated With an Increased Risk of Urinary Tract Infection and BK Viremia

  • Eman A. Alshaikh, MD,
  • Brad C. Astor, PhD,
  • Brenda Muth, NP,
  • Margaret Jorgenson, PharmD,
  • Kurt Swanson, MD,
  • Neetika Garg, MD,
  • Fahad Aziz, MD,
  • Maha Mohamed, MD,
  • Didier Mandelbrot, MD,
  • Sandesh Parajuli, MD

DOI
https://doi.org/10.1097/TXD.0000000000001526
Journal volume & issue
Vol. 9, no. 9
p. e1526

Abstract

Read online

Background. Delayed graft function (DGF) among deceased donor kidney transplant recipients (DDKTRs) is a well-known risk factor for allograft rejection, decreased graft survival, and increased cost. Although DGF is associated with an increased risk of rejection, it is unclear whether it also increases the risk of infection. Methods. We reviewed all adult DDKTRs at our center between 2010 and 2018. The primary outcomes of interest were BK viremia, cytomegalovirus viremia, pneumonia, and urinary tract infection (UTI) within the first year of transplant. Additional analysis was made with censoring follow-up at the time of allograft rejection. Results. A total of 1512 DDKTRs were included, of whom 468 (31%) had DGF. As expected, several recipient, donor, and baseline immunological characteristics differed by DGF status. After adjustment, DGF was significantly associated with an increased risk of BK viremia (hazard ratio: 1.34; 95% confidence interval, 1.0-1.81; P = 0.049) and UTI (hazard ratio: 1.70; 95% confidence interval, 1.31-2.19; P < 0.001) but not cytomegalovirus viremia or pneumonia. Associations were similar in models censored at the time of rejection. Conclusions. DGF is associated with an increased risk of early infectious complications, mainly UTI and BK viremia. Close monitoring and appropriate management are warranted for better outcomes in this unique population.